Spotlight
Video

Annual Meeting LC Highlights, Pt 6: Benefit of Chemotherapy vs. EGFR Inhibitor Therapy in Second Line

cancergrace has 804 videos Subscribe Here

Loading........
Description: http://cancerGRACE.org...

Dr. David Gerber, University of Texas-Southwestern, reviews the results of the PROSE study of the Veristrat serum proteomics test to predict benefit of chemo or EGFR inhibitor for second line treatment of advanced lung cancer.

GRACEcast 165 Lung
Shared By : cancergrace
Posted on : 08/23/13
Added : 4 years ago
Category : Other